Thank you
HCPs are more digitally savvy now than ever. However, digital engagement with pharmaceutical companies and their representatives remains elusive. There is a need to understand HCP content and channel preferences and their evolving needs to ensure successful delivery of relevant content, but these preferences often vary at a regional, experience and specialty level which is a critical input for communications planning.
This ISMPP U will highlight the different preferences of HCPs for pharma engagement and how to appeal to HCPs around the world in an effective and efficient manner.
Learning objectives:
- Understanding a HCP’s perspective on how the COVID-19 pandemic has changed their consumption habits and the challenges faced
- Understanding strategies which the industry can utilise to keep up with changing HCP interaction trends
Description
HCPs are more digitally savvy now than ever. However,
digital engagement with pharmaceutical companies and their representatives
remains elusive. There is a need to understand HCP content and channel
preferences and their evolving needs to ensure successful delivery of relevant
content, but these preferences often vary at a regional, experience and
specialty level which is a critical input for communications planning.
This ISMPP U will highlight the different preferences of
HCPs for pharma engagement and how to appeal to HCPs around the world in an
effective and efficient manner.
Learning objectives:
- Understanding a HCP’s perspective on how the COVID-19 pandemic has changed their consumption habits and the challenges faced
- Understanding strategies which the industry can utilise to keep up with changing HCP interaction trends